BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36169629)

  • 1. Pharmacogenomics in psychiatry - the challenge of cytochrome P450 enzyme phenoconversion and solutions to assist precision dosing.
    Mostafa S; Polasek TM; Bousman CA; Müeller DJ; Sheffield LJ; Rembach J; Kirkpatrick CM
    Pharmacogenomics; 2022 Oct; 23(15):857-867. PubMed ID: 36169629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.
    Mostafa S; Kirkpatrick CMJ; Byron K; Sheffield L
    J Neural Transm (Vienna); 2019 Jan; 126(1):5-18. PubMed ID: 30191366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Pharmacogenomics on Pediatric Psychotropic Medication Prescribing in an Ambulatory Care Setting.
    Tonti E; Lee YM; Gruenke N; Ferren J; Stutzman DL
    J Child Adolesc Psychopharmacol; 2024 Feb; 34(1):52-60. PubMed ID: 38377527
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
    Del Toro-Pagán NM; Matos A; Thacker D; Turgeon J; Amin NS; Michaud V
    Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Pharmacogenomics Testing of Cytochrome P450 Enzymes in the Military Health System From 2015 to 2020.
    Por ED; Selig DJ; Chin GC; DeLuca JP; Oliver TG; Livezey JR
    Mil Med; 2021 Dec; 187(Suppl 1):1-8. PubMed ID: 34967404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics: an Update for Child and Adolescent Psychiatry.
    Namerow LB; Walker SA; Loftus M; Bishop JR; Ruaño G; Malik S
    Curr Psychiatry Rep; 2020 May; 22(5):26. PubMed ID: 32377970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Narrative Review on Pharmacogenomics in Psychiatry: Scientific Definitions, Principles, and Practical Resources.
    Palumbo S; Mariotti V; Pellegrini S
    J Clin Psychopharmacol; 2024 Jan-Feb 01; 44(1):49-56. PubMed ID: 38100778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
    Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL
    J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy.
    Pratt VM; Cavallari LH; Del Tredici AL; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; van Schaik RHN; Whirl-Carrillo M; Weck KE
    J Mol Diagn; 2021 Sep; 23(9):1047-1064. PubMed ID: 34118403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review and Consensus on Pharmacogenomic Testing in Psychiatry.
    Bousman CA; Bengesser SA; Aitchison KJ; Amare AT; Aschauer H; Baune BT; Asl BB; Bishop JR; Burmeister M; Chaumette B; Chen LS; Cordner ZA; Deckert J; Degenhardt F; DeLisi LE; Folkersen L; Kennedy JL; Klein TE; McClay JL; McMahon FJ; Musil R; Saccone NL; Sangkuhl K; Stowe RM; Tan EC; Tiwari AK; Zai CC; Zai G; Zhang J; Gaedigk A; Müller DJ
    Pharmacopsychiatry; 2021 Jan; 54(1):5-17. PubMed ID: 33147643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving Pain Management with Pharmacogenomics: A General Introduction.
    Schuh MJ; Randles H; Crosby S
    J Pain Palliat Care Pharmacother; 2020 Sep; 34(3):114-119. PubMed ID: 32186418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP2D6 pharmacogenetics and phenoconversion in personalized medicine.
    Nahid NA; Johnson JA
    Expert Opin Drug Metab Toxicol; 2022 Nov; 18(11):769-785. PubMed ID: 36597259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to Integrate CYP2D6 Phenoconversion Into Clinical Pharmacogenetics: A Tutorial.
    Cicali EJ; Elchynski AL; Cook KJ; Houder JT; Thomas CD; Smith DM; Elsey A; Johnson JA; Cavallari LH; Wiisanen K
    Clin Pharmacol Ther; 2021 Sep; 110(3):677-687. PubMed ID: 34231197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global spectrum of population-specific common missense variation in cytochrome P450 pharmacogenes.
    Chong CS; Limviphuvadh V; Maurer-Stroh S
    Hum Mutat; 2021 Sep; 42(9):1107-1123. PubMed ID: 34153149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics in Psychiatry Practice: The Value and the Challenges.
    Alchakee A; Ahmed M; Eldohaji L; Alhaj H; Saber-Ayad M
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implementation of preemptive pharmacogenomics in psychiatry: Τhe "PREPARE" study.
    Tsermpini EE; Skokou M; Ferentinos P; Georgila E; Gourzis P; Assimakopoulos K; Patrinos GP;
    Psychiatriki; 2020; 31(4):341-351. PubMed ID: 33361064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics - a minor rather than major force in clinical medicine.
    Polasek TM
    Expert Rev Clin Pharmacol; 2024 Mar; 17(3):203-212. PubMed ID: 38307498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying the Impact of Phenoconversion on Medications With Actionable Pharmacogenomic Guideline Recommendations in an Acute Aged Persons Mental Health Setting.
    Mostafa S; Polasek TM; Sheffield LJ; Huppert D; Kirkpatrick CMJ
    Front Psychiatry; 2021; 12():724170. PubMed ID: 34489765
    [No Abstract]   [Full Text] [Related]  

  • 19. The usefulness of genotyping cytochrome P450 enzymes in the treatment of depression.
    Dubovsky SL
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):369-79. PubMed ID: 25554071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perception and knowledge of pharmacogenetics among Brazilian psychiatrists.
    Almeida BC; Gonçalves ED; de Sousa MH; Osis MJMD; de Brito Mota MJB; Planello AC
    Psychiatry Res; 2021 Dec; 306():114238. PubMed ID: 34656849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.